FDA Panel Endorses Pfizer Shots for 5- to 11-Year-Olds

October 27th, 2021

Via: The Defender:

The U.S. Food and Drug Administration’s advisory panel today voted to recommend the agency allow Pfizer to amend its Emergency Use Authorization for its COVID vaccine for children 5 through 11 years old, despite a host of objections from scientists and physicians.

Leave a Reply

You must be logged in to post a comment.